Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia

View ORCID ProfileAidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie A. Prystajecky, Agatha N. Jassem, Mel Krajden, David M Patrick, Inna Sekirov
doi: https://doi.org/10.1101/2020.11.23.20237206
Aidan M. Nikiforuk
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aidan M. Nikiforuk
Kevin S. Kuchinski
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David D.W. Twa
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
3British Columbia Cancer Research Centre, Vancouver, V5Z 1L3, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine D. Lukac
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hind Sbihi
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Andrew Basham
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Steidl
3British Columbia Cancer Research Centre, Vancouver, V5Z 1L3, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie A. Prystajecky
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agatha N. Jassem
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mel Krajden
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M Patrick
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inna Sekirov
1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: inna.sekirov@bccdc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background Angiotensin converting enzyme 2 (ACE2) serves as the host receptor for SARS-CoV-2, with a critical role in viral infection. We aim to understand population level variation of nasopharyngeal ACE2 expression in people tested for COVID-19 and the relationship between ACE2 expression and SARS-CoV-2 viral RNA load, while adjusting for expression of the complementary protease, Transmembrane serine protease 2 (TMPRSS2), soluble ACE2, age, and biological sex.

Methods A cross-sectional study of n=424 participants aged 1-104 years referred for COVID-19 testing was performed in British Columbia, Canada. Participants who tested negative or positive for COVID-19 were matched by age and biological sex. Viral and host gene expression was measured by quantitative reverse-transcriptase polymerase chain reaction. Bivariate analysis and multiple linear regression were performed to understand the role of nasopharyngeal ACE2 expression in SARS-CoV-2 infection. The ACE2 gene was targeted to measure expression of transmembrane and soluble transcripts.

Findings Analysis shows no association between age and nasopharyngeal ACE2 expression in those who tested negative for COVID-19 (P=0·092). Mean expression of transmembrane (P=1·2e-4), soluble ACE2 (P<0·0001) and TMPRSS2 (P<0·0001) differed between COVID-19-negative and -positive groups. In bivariate analysis of COVID-19-positive participants, expression of transmembrane ACE2 positively correlated with SARS-CoV-2 RNA viral load (P<0·0001), expression of soluble ACE2 negatively correlated (P<0·0001), and no correlation was found with TMPRSS2 (P=0·694). Multivariable analysis showed that the greatest viral RNA loads were observed in participants with high transmembrane ACE2 expression (B=0·886, 95%CI:[0·596 to 1·18]), while expression of soluble ACE2 may protect against high viral RNA load in the upper respiratory tract (B= −0·0990, 95%CI:[−0·176 to −0·0224]).

Interpretation Nasopharyngeal ACE2 expression plays a dual, contrasting role in SARS-CoV-2 infection of the upper respiratory tract. Transmembrane ACE2 positively correlates, while soluble ACE2 negatively correlates with viral RNA load after adjusting for age, biological sex and expression of TMPRSS2.

Funding This project (COV-55) was funded by Genome British Columbia as part of their COVID-19 rapid response initiative.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project (COV-55) was funded by Genome British Columbia as part of their COVID-19 rapid response initiative. The funder and data stewards played no role in the study design, analysis or interpretation of the results. As such, interpretation of the results does not reflect the views of the funding organization or data stewards. The study was performed as research at the University of British Columbia and British Columbia Centre for Disease Control.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for the study was obtained from the University of British Columbia human ethics board (H20-01110).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the data steward but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the data steward.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
Aidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie A. Prystajecky, Agatha N. Jassem, Mel Krajden, David M Patrick, Inna Sekirov
medRxiv 2020.11.23.20237206; doi: https://doi.org/10.1101/2020.11.23.20237206
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
Aidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie A. Prystajecky, Agatha N. Jassem, Mel Krajden, David M Patrick, Inna Sekirov
medRxiv 2020.11.23.20237206; doi: https://doi.org/10.1101/2020.11.23.20237206

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (452)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5268)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (699)
  • Health Policy (360)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5889)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (143)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (98)
  • Psychiatry and Clinical Psychology (864)
  • Public and Global Health (2021)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)